RECRUITING

mHealth-CArdiac REhabilitation for INOCA

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a multi-site phase II, 2:1 pragmatic randomized trial of 250 participants within the NYU Langone Health (NYULH) and Emory University Medical Center system to evaluate mobile health cardiac rehabilitation (mHealth-CR) in patients who meet clinical criteria for INOCA (ischemia and no obstructive coronary disease on imaging). Participants will be randomized to mHealth-CR or usual care. The study intervention takes place for 3 months which is the time period for most traditional CR programs. The overall study goals are threefold: 1) to evaluate whether an mHealth-CR intervention that includes activity tracking, weekly counseling, and exercise documentation, improves health status (i.e., symptoms, function, and quality of life) in patients with INOCA at 3 months; 2) to evaluate effects of the mHealth-CR intervention vs. usual care on physical activity and exercise capacity, general health status, and depressive symptoms (secondary endpoints). We will also evaluate effects on primary and secondary outcomes at 6 months and 1 year; and 3) to characterize engagement and elucidate any factors that limit engagement.

Official Title

mHealth-CArdiac REhabilitation for INOCA (INOCA-CARE)

Quick Facts

Study Start:2025-03-21
Study Completion:2028-02
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06829160

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 18 and over
  2. * Diagnosis of Ischemia with Non-Obstructive Coronary Arteries (INOCA) based on evidence of ischemia and/or ischemic symptoms, plus non-obstructive Coronary artery disease (CAD) on computed tomography (CT) or invasive angiography
  1. * Seattle Angina Questionnaire (SAQ) = 100
  2. * Non-ambulatory
  3. * Pregnant
  4. * Moderate or severe cognitive impairment
  5. * Unable/willing to provide consent
  6. * Incarcerated
  7. * Unable to use mHealth
  8. * Severe osteoarthritis or joint replacement within 3 months
  9. * Parkinsons disease or other movement disorders
  10. * Regular use of walker
  11. * Life expectancy \< 12 months
  12. * Clinical judgement concerning other safety or non-adherence issues
  13. * Unable to read and communicate in English since the app content is currently only available in English.

Contacts and Locations

Study Contact

Harmony Reynolds, MD
CONTACT
212-263-7751
INOCA@nyulangone.org
John Dodson, MD
CONTACT
212-263-7751
INOCA@nyulangone.org

Principal Investigator

Harmony Reynolds, MD
PRINCIPAL_INVESTIGATOR
NYU Langone Health

Study Locations (Sites)

NYU Langone Health
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • Harmony Reynolds, MD, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-03-21
Study Completion Date2028-02

Study Record Updates

Study Start Date2025-03-21
Study Completion Date2028-02

Terms related to this study

Keywords Provided by Researchers

  • INOCA
  • ANOCA
  • Ischemia
  • no obstructive coronary artery disease

Additional Relevant MeSH Terms

  • Ischemia